Indolent
Disease is present but biologically quiet, understanding what is keeping it that way.
Disease is present, but for most men it will remain exactly where it is, quiet, slow, and requiring understanding far more than it requires intervention.
3 papers. Why they matter here.
- Paper 1
Mutations Provide Potential, but Environment Determines Expression
Read the paper →Explains why most diagnosed prostate cancer remains biologically quiet, and what the ecological conditions of containment actually are.
- Paper 2
Tumour Ecology and Evolutionary Stability
Read the paper →The ecological model of containment. Why the tumour microenvironment actively maintains stability and what disrupts it.
- Paper 3
PSA Kinetics and the Natural History of Prostate Cancer
Read the paper →Johansson and Albertsen: the empirical evidence that most indolent disease remains contained for years to decades. PSA kinetics as the primary monitoring tool.
12 papers. Why they matter here.
- Paper 1
The Primer
Read the paper →Containment as the biological default. What maintaining that default requires.
- Paper 2
MDM2 as Convergence Point
Read the paper →The upstream metabolic conditions sustaining containment, and what happens when they are disrupted.
- Paper 3
Rapamycin, mTOR Oscillation, and the p53-MDM2 Axis
Read the paper →How cyclic mTOR suppression restores the quality-control rhythm that containment depends on.
- Paper 4
The Three Layers of Intervention
Read the paper →Output, signalling, and structural layers. Why durable containment requires acting at all three depths simultaneously.
- Paper 5
Signal, Stress, and Selection
Read the paper →The four-signal temporal architecture. How the sequence of interventions preserves containment without creating new selection pressures.
- Paper 6
Dynamic Fitness Landscapes and Evolutionary Constraint in Prostate Cancer
Read the paper →Why tumour populations cannot reach stable adaptive optima in an oscillating environment. The evolutionary argument for containment over elimination in indolent disease.
- Paper 7
From Intervention to Environment
Read the paper →The operational logic of constraint-based management. Why the sequence is the mechanism.
- Paper 8
Doxycycline: Multi-Pillar Analysis
Read the paper →Four convergent mechanisms for constraining the conditions that indolent disease would need to progress.
- Paper 9
Pioglitazone at Low Dose
Read the paper →Sustained stromal and metabolic remodelling across the containment phase.
- Paper 10
Testosterone, p53, and the MDM2 System
Read the paper →Preserving AR dependence during the indolent phase. Why physiological TRT supports containment.
- Paper 11
Oestrogen's Role in Prostate Cancer
Read the paper →The oestrogen conditions that either support or undermine containment.
- Paper 12
A Hierarchy of Biological Signals
Read the paper →Phase 2 monitoring operates at Level 2, trajectory signals. PSA velocity, doubling time, and pattern coherence as the primary tools for confirming containment is holding.